Phenotype Standardization for Immune-Mediated Drug-Induced Skin Injury

DRUG HYPERSENSITIVITY

(2014) N. Yawalkar   ACTA CLINICA BELGICA

The Phenotype Standardization Project: Improving Pharmacogenetic Studies of Serious Adverse Drug Reactions

(2011) M Pirmohamed et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

HLA-A*3101 and Carbamazepine-Induced Hypersensitivity Reactions in Europeans

(2011) Mark McCormack et al.   NEW ENGLAND JOURNAL OF MEDICINE

ALDEN, an Algorithm for Assessment of Drug Causality in Stevens–Johnson Syndrome and Toxic Epidermal Necrolysis: Comparison With Case–Control Analysis

(2010) B Sassolas et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

Genome-wide association study identifies HLA-A*3101 allele as a genetic risk factor for carbamazepine-induced cutaneous adverse drug reactions in Japanese population

(2010) Takeshi Ozeki et al.   HUMAN MOLECULAR GENETICS

Methods for Causality Assessment of Adverse Drug Reactions

(2009) Taofikat B Agbabiaka et al.   DRUG SAFETY

The Variable Clinical Picture of Drug-Induced Hypersensitivity Syndrome/Drug Rash with Eosinophilia and Systemic Symptoms in Relation to the Eliciting Drug

(2009) Yoko Kano et al.   IMMUNOLOGY AND ALLERGY CLINICS OF NORTH AMERICA

Association of HLA-BFNx011502 allele and carbamazepine-inducedStevens-Johnson syndromeamong Indians

(2009) TimirY Mehta et al.   Indian Journal of Dermatology Venereology & Leprology

Stevens–Johnson syndrome and toxic epidermal necrolysis

(2008) Andrea T. Borchers et al.   AUTOIMMUNITY REVIEWS

Carbamazepine and phenytoin induced Stevens-Johnson syndrome is associated with HLA-B*1502 allele in Thai population

(2008) Chaichon Locharernkul et al.   EPILEPSIA

Stevens–Johnson Syndrome and Toxic Epidermal Necrolysis: Assessment of Medication Risks with Emphasis on Recently Marketed Drugs. The EuroSCAR-Study

(2007) Maja Mockenhaupt et al.   JOURNAL OF INVESTIGATIVE DERMATOLOGY